In 2024, the tennis community faced two significant doping scandals. The first involved Jannik Sinner, whose controversy emerged during his successful campaign at the US Open. Just one week prior to the tournament, the International Tennis Integrity Agency (ITIA) disclosed that he had tested positive for clostebol on two occasions in March. However, an independent tribunal accepted his argument of unintentional contamination. In September, the World Anti-Doping Agency (WADA) appealed this decision to the Court of Arbitration for Sport (CAS), which agreed to hear the case. A ruling from CAS is expected next year.

The second incident involved Iga Swiatek in late November when the ITIA announced that a sample collected from her in August tested positive due to unintentional contamination from melatonin pills produced and sold in Poland. Following the US Open, she received a provisional suspension lasting 22 days and subsequently served a one-match ban, which concluded this month.

In response to these doping issues, Novak Djokovic voiced his dissatisfaction with the handling of the situation. “I have been quite frustrated ... to see that we have been kept in the dark for at least five months regarding the Jannik case,” he remarked at the Brisbane International.

“The ATP has not provided substantial commentary on the matter. Why has this case been withheld from public knowledge?

“We are witnessing Simona Halep's situation on the WTA Tour, and now Iga's case. This does not reflect well on our sport.”

Implying potential corruption in the investigations, he noted discrepancies in how players are treated in similar circumstances. “I am questioning the integrity of the system and why certain players receive different treatment than others. Perhaps there are ranking considerations at play, or some players possess greater financial resources and more robust legal teams to navigate these issues,” he stated in a public address to the ITIA.

Additionally, the ITIA released a report indicating that Swiatek had provided a list of 14 medications or supplements she was taking. Following the ITIA's decision regarding Swiatek, Simona Halep criticized the organization for its perceived double standards, drawing comparisons to her own treatment.

Read Also: "Rohit Sharma's Passionate Plea to Siraj: Step Up and Don't Rely on Bumrah"

HOW DID YOU LIKE THIS ARTICLE? CHOOSE YOUR EMOTICON!